Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Junqing (Frank) Xie who has been awarded the Stanley A. Edlavitch Award from The International Society for Pharmacoepidemiology (ISPE).

Frank Xie receives his award from ISPE
Anton Pottegård (l), Chair, of the Scientific Program Committee of the 38th ISPE presents the Stanley A. Edlavitch Award to Junqing (Frank) (r)

The award, named after the Society's first executive director, is presented each year to the student/Post-Doc who submits the most highly rated abstract for presentation at the meeting.

Frank's paper is called: Genetic risk and incident venous thromboembolism in middle-aged and older adults following Covid-19 vaccination.

The research, pre-printed in medRxiv, set out to explore whether the genetic risk for venous blood clots, aka venous thromboembolism (VTE) changes following the Covid-19 vaccination. They discovered that known genetic variants associated with VTE in the general population remain associated with the risk of VTE after Covid-19 vaccination. This genetic risk appeared unlikely to be altered by large-scale vaccination.

Frank was presented with the award at the ICPE 2022 on Saturday, August 28 in Copenhagen.

On receiving the award Frank said: "This finding built on large Real-World and Biobank genetic data deeps our understanding of the safety of Covid-19 vaccines, showing promise of accelerating interdisciplinary research in NDORMS, University of Oxford."

Similar stories

MRC funding awarded to Kennedy researchers

Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.

Daniel Prieto-Alhambra receives ISPE award for COVID-19 research

Daniel Prieto-Alhambra has been awarded the 'Special ISPE award for contributions to public health associated with the COVID-19 pandemic.'

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination

Researchers at NDORMS have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.